临床试验/IRCT20210519051345N38

IRCT20210519051345N38招募中Unknown

Fasted-state in vivo bioequivalence study of Calcium Dobesilate 500 mg Capsule manufactured by Abyan Pharmed compared with innovator product

Tabriz University of Medical Sciences0 个研究点目标入组 24 人开始时间: 待定最近更新: 2024年1月22日

试验速览

阶段: Unknown
状态: 招募中
发起方: Tabriz University of Medical Sciences
入组人数: 24

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型: Interventional

入排标准

年龄范围: 18 years 至 59 years（—）
性别: All

入选标准

•General Health (in terms of Liver, Heart and Kidney)
•Age (18-59 years)

排除标准

•History of cardiovascular disease, liver and kidney disease
•Alcohol and drug addiction
•History of drug allergy

研究者

发起方

Tabriz University of Medical Sciences

相似试验

Investigating the in vivo bioequivalence of Celecoxib 100 mg tablet

IRCT20210519051345N15Tabriz University of Medical Sciences24

Bioequivalence study of Gliclazide 60 mg tablet

IRCT20210519051345N63Tabriz University of Medical Sciences24

Bioequivalence study of Gliclazide 60 mg tablet

IRCT20210519051345N43Tabriz University of Medical Sciences24

Comparison of the effect of administration Calcium-Vitamin D and Metformin in Regulating Menstrual Cycle in person with an ovulatioPolycystic ovarian syndrome.Polycystic ovarian syndrome

IRCT201705084850N4Vice-Chancellor for Research of Qazvin University of Medical Sciences102

In vivo Bioequivalence study of Baricitinib tabletsIn the present study, the products will be administered to healthy volunteers..

IRCT20220211053992N24Tabriz University of Medical Sciences24